Skip to content
Screener
908 Devices logo

908 Devices

MASS

908 Devices Inc. is a life sciences technology company that develops purpose-built handheld devices for point-of-need chemical analysis.

Market cap
$475.75M+123%
Revenue$65.8M+23.8%
Net income-$24.3M-487%
EPS (diluted)-$0.64-482%
Trailing twelve months · change vs. prior year

Earnings

Next report

Date not yet announced

Financials

Q3 2026

Income statement

See full
Revenue$19.0M+35.3%
Gross profit$10.0M+36.2%
Operating income-$5.5M+66.4%
Net income-$4.6M+69.4%
EPS (diluted)-$0.11+73.2%

Balance sheet

See full
Cash & equivalents$63.6M+1.3%
Total debt$5.0M+15.9%
Total equity$149.8M+9.9%
Total assets$199.4M+4.4%

Cash flow

See full
CapEx$65.0K-90.4%

Valuation & ratios

Valuation

See full
Market cap$475.75M+123%
Enterprise value$417.19M+142%
P/S7.2×+2.9×

Profitability

See full
Gross margin52.3%+3.5pp
Operating margin-47.4%-17.3pp
Net margin-36.9%-50.3pp

Returns & leverage

See full
Return on equity-17%-21.8pp
Debt / equity0×0.0×
Current ratio5.4×+1.9×

Segments

By geography

See full
Asia Pacific$4.8M+503%
EMEA$2.3M+52.2%
Americas Other$431.0K-2.7%

By product

See full
Device Sales$13.9M+52.2%
Recurring$5.1M+5.1%

By segment

See full
Single Reportable$19.0M+35.3%

Competitors

Profile

908 Devices Inc. is a life sciences technology company that develops purpose-built handheld devices for point-of-need chemical analysis. By leveraging miniaturized mass spectrometry and optical spectroscopy, the company provides front-line workers with the ability to identify unknown substances, including illicit drugs and toxic chemicals, in real-time. Their core value proposition lies in transforming complex laboratory-grade analytical technology into simple, rugged, and accessible tools for critical health, safety, and defense applications.

Competitive position

The company is a pioneer in the miniaturization of mass spectrometry, offering the first truly handheld devices in a market traditionally dominated by large, stationary laboratory instruments.

GeographiesUnited States, International
Customer segmentsPublic safety, Government, Military, Healthcare
Business modelHardware manufacturing, Consumables and accessories sales
SuppliersSemiconductor microfabrication services, Electronic component suppliers, Specialized chemical and optical component providers
CustomersHazmat teams, CBRNE (Chemical, Biological, Radiological, Nuclear, and Explosives) units, Border protection agencies, Forensic laboratories
Listed2020
Employees230.0
CEOKevin J. Knopp
FilingsSEC EDGAR

FAQ

What is 908 Devices's market cap?
908 Devices (MASS) has a market capitalization of $475.8M and trades on NASDAQ.
What is 908 Devices's revenue and profitability?
908 Devices generated $65.8M in trailing twelve-month revenue with a net loss of $24.3M, representing a net margin of -36.9%. Gross margin stands at 52.3%. The latest reported period is Q3 2026.
Who are 908 Devices's competitors?
908 Devices's key competitors include Agilent Technologies, Inc., Bruker Corporation, Waters Corporation, and others. These companies compete in similar markets and product categories.
What subsidiaries does 908 Devices have?
908 Devices's subsidiaries include RedWave Technology.
Where is 908 Devices headquartered?
908 Devices is headquartered in United States of America and employs approximately 230 people. It has been publicly traded since 2020.